Trial update
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH): registry status update
The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.